COVID-19 Associated Coagulopathy and Implications for its Treatment
The SARS-CoV-2 coronavirus (COVID-19) pandemic is due to lack of prior immunity and there is no certain management, regarding the complications of this viral illness. The target organ for COVID-19 infection are the lungs. Patients may develop acute lung injury that can be complicated by acute respir...
Guardado en:
Autores principales: | Cherneva Zh., Cherneva R. |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Sciendo
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/568b7f711ad346d6bbaee40ca12a0804 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Characteristics and treatment of coagulopathy associated with COVID-19
por: Miljić Predrag
Publicado: (2021) -
COVID-19-associated coagulopathy in children and adolescents
por: M. V. Gomellya, et al.
Publicado: (2021) -
Diagnostic and prognostic value of Sepsis-Induced coagulopathy and International Society on Thrombosis and Hemostasis scoring systems in COVID-19-associated disseminated intravascular coagulopathy
por: Sayyideh Forough Hosseini, et al.
Publicado: (2021) -
TEG<sup>®</sup>, Microclot and Platelet Mapping for Guiding Early Management of Severe COVID-19 Coagulopathy
por: Gert Jacobus Laubscher, et al.
Publicado: (2021) -
Burn management during the COVID-19 pandemic: recommendations and considerations
por: Amjad Soltany, et al.
Publicado: (2020)